200 related articles for article (PubMed ID: 11760554)
1. NCCN: Fever and neutropenia.
Wade JC; Rubenstein EB;
Cancer Control; 2001; 8(6 Suppl 2):16-21. PubMed ID: 11760554
[No Abstract] [Full Text] [Related]
2. Quinupristin/dalfopristin and linezolid: spectrum of activity and potential roles in therapy--a status report.
Batts DH; Lavin BS; Eliopoulos GM
Curr Clin Top Infect Dis; 2001; 21():227-51. PubMed ID: 11572153
[No Abstract] [Full Text] [Related]
3. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM
J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908
[TBL] [Abstract][Full Text] [Related]
4. [Treatment and prevention of infections in cancer patients with neutropenia].
Sinkó J
Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
[TBL] [Abstract][Full Text] [Related]
5. Linezolid resistant enterococcus faecium.
McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
[No Abstract] [Full Text] [Related]
6. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?
Livermore DM
J Antimicrob Chemother; 2000 Sep; 46(3):347-50. PubMed ID: 10980159
[No Abstract] [Full Text] [Related]
7. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
Bal AM; Gould IM
Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
[TBL] [Abstract][Full Text] [Related]
8. [Enterococcus faecalis meningitis after spinal anesthesia successfully managed with linezolid].
Cournac JM; Landais C; Gaillard T; Bordes J; Carli P
Med Mal Infect; 2012 Jul; 42(7):327-8. PubMed ID: 22727505
[No Abstract] [Full Text] [Related]
9. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
10. [Prolonged treatment with linezolid with good hematologic tolerability].
Ramos A; García MJ; Blasco F; Valverde ML
Rev Esp Quimioter; 2004 Sep; 17(3):266-7. PubMed ID: 15619657
[No Abstract] [Full Text] [Related]
11. Linezolid: a new antibiotic for gram-positive infections.
Wilson P
Hosp Med; 2001 Nov; 62(11):682-6. PubMed ID: 11762099
[TBL] [Abstract][Full Text] [Related]
12. [Antibiosis. Therapeutic strategies in intensive care].
Chirurg; 1999 Nov; 70(11 Suppl):1-8. PubMed ID: 10599516
[No Abstract] [Full Text] [Related]
13. Summaries for patients. Linezolid.
Ann Intern Med; 2003 Jan; 138(2):I44. PubMed ID: 12529109
[No Abstract] [Full Text] [Related]
14. Neutropenia and fever in patients receiving chemotherapy in a community teaching hospital: results of a retrospective chart review.
Obadina M; Cho C; Oketunji A; Waterfield W
Md Med J; 1994 Nov; 43(11):977-80. PubMed ID: 7808201
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy.
Cordonnier C; Buzyn A; Leverger G; Herbrecht R; Hunault M; Leclercq R; Bastuji-Garin S;
Clin Infect Dis; 2003 Jan; 36(2):149-58. PubMed ID: 12522746
[TBL] [Abstract][Full Text] [Related]
16. New antibiotics for gram positive infections: linezolid and combination quinapristin/dalfopristin.
MacConnachie AM
Intensive Crit Care Nurs; 1999 Aug; 15(4):239-41. PubMed ID: 10786510
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobials in the treatment of orthopaedic prosthetic infections.
Parra-Ruiz J; Martinez M; Antelo-Lorenzo R; Hernández-Quero J
J Antimicrob Chemother; 2004 May; 53(5):886-7; author reply 887. PubMed ID: 15056648
[No Abstract] [Full Text] [Related]
18. Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
Schweiger ES; Scheinfeld NS; Tischler HR; Weinberg JM
J Drugs Dermatol; 2003 Aug; 2(4):378-83. PubMed ID: 12884459
[TBL] [Abstract][Full Text] [Related]
19. Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections.
Brickner SJ; Barbachyn MR; Hutchinson DK; Manninen PR
J Med Chem; 2008 Apr; 51(7):1981-90. PubMed ID: 18338841
[No Abstract] [Full Text] [Related]
20. Quinupristin-dalfopristin and linezolid: evidence and opinion.
Eliopoulos GM
Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
